Client Alerts & Insights
CDC Provides Updated Recommendations on COVID-19 Quarantine and Isolation Times
December 28, 2021
On December 27, 2021, the Centers for Disease Control and Prevention (“CDC”) provided new guidance regarding its recommended times for quarantine and isolation for individuals exposed to COVID-19. Employers that have chosen to follow the CDC’s advisory guidance to date may consider revising their practices in light of the CDC’s update.
Isolation Timeframe Following Infection
Regardless of vaccination status, if any individual has a confirmed COVID-19 infection, the CDC encourages that individual to isolate for 5 days and, if asymptomatic at that time, the individual may leave isolation while continuing to wear a mask when around others for an additional 5 days. Individuals who have a fever 5 days after their infection was confirmed should continue to stay home until the fever resolves.
Quarantine Timeframes Following Exposure
Per the new guidance, individuals that were exposed to someone with COVID-19 and (a) are unvaccinated or (b) are vaccinated but more than 6 months removed from their second dose of the Pfizer or Moderna vaccines (or more than 2 months removed from their dose of the Johnson & Johnson vaccine) and are not boosted should quarantine for 5 days, followed by an additional 5 days of mask use when around others.
For individuals who have received booster doses of their respective vaccines, the CDC advises that, while quarantine is not necessary following an exposure, these individuals should nevertheless wear a mask for 10 days after exposure.
If quarantining is infeasible, the CDC strongly recommends that all exposed individuals wear a well-fitting mask at all times when around others for 10 days after exposure to mitigate COVID-19’s spread. Additionally, the CDC notes that it would be best practice to test for the virus 5 days after exposure and, if symptoms occur, to quarantine until a negative test confirms that the symptoms are not COVID-19 related.
Although the CDC’s guidance is advisory, employers should stay apprised of state or local rules that impose mandatory masking and/or vaccination requirements.
Please reach out to Benesch’s Labor & Employment Practice Group for more information.
Corey Clay at cclay@beneschlaw.com or 216.363.6196.
Latest News
Medical First, Recreational Later? DOJ’s Cannabis Order and the Stakes Ahead
DOJ’s April 2026 order immediately moved FDA-approved and state-licensed medical cannabis to Schedule III, removing harsh tax penalties for medical operators, while leaving adult-use cannabis under stricter Schedule I controls pending further administrative review.
New Sentencing Guidelines for Economic Crimes Effective November 1, 2026
In March we reported on the U.S. Sentencing Commission’s proposed amendments to the Federal Sentencing Guidelines (the “Guidelines”). On April 16, 2026, the bipartisan United States Sentencing Commission (the “Commission”) voted unanimously to adopt that package of amendments, without modification.
Judicial Green Light: Court Upholds NLRB’s Cemex Decision
On April 21st, 2026, the U.S. Court of Appeals for the Ninth Circuit upheld the National Labor Relations Board’s (“NLRB”) decision in Cemex Construction Materials Pacific, LLC., reinforcing a significant shift in federal labor law governing union recognition and employer conduct during organizing campaigns.
The LEAD Model—Kidney Care’s Value-Based Care Journey LEADs Here
The new LEAD Model, launching in 2027, is CMS’s next-generation value-based care framework for kidney care, integrating CKD and ESRD patients into standard ACOs with a 10-year benchmark period, new payment options and greater flexibility for nephrology-led organizations.